Muscle-invasive Bladder Cancer
📧 Sign up to get email alerts when something new happens for Muscle-invasive Bladder Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2022-12-28Clinical Trial Update: Comprehensive Bladder Preservation Therapy on Patients With Muscle Invasive Bladder Cancer [Phase 2]
Phase 2 clinical trial update on bladder-preservation therapy for muscle-invasive bladder cancer.
-
CLINICAL_TRIALS trial_result · 2022-11-30Clinical Trial Update: Perioperative Tislelizumab Combined With Nab-Paclitaxel for Muscle-invasive Urothelial Bladder Carcinoma [Phase 2]
Phase 2 trial evaluating perioperative tislelizumab with nab-paclitaxel for muscle-invasive urothelial bladder cancer shows an ongoing study…
-
CLINICAL_TRIALS trial_result · 2022-10-26Clinical Trial Update: Efficacy of Atezolizumab Concurrent With Radiotherapy in Patients With Muscle-invasive Bladder cáncer [Phase 2]
Phase 2 trial evaluating atezolizumab given concurrently with radiotherapy in patients with muscle-invasive bladder cancer.
-
CLINICAL_TRIALS trial_result · 2022-08-18Clinical Trial Update: Bladder Sparing Treatment of Tislelizumab, Gemcitabine and Cisplatin for Patients With PD-L1 Positive Muscle Invasive Bladder Cancer [Phase 2]
Phase 2 trial update investigating a bladder-sparing regimen of tislelizumab plus gemcitabine and cisplatin for PD-L1 positive muscle-invasi…
-
CLINICAL_TRIALS trial_result · 2022-06-13Clinical Trial Update: Perioperative Tislelizumab Combined With Nab-Paclitaxel for Muscle-invasive Urothelial Bladder Cancer: A Multicenter Study [Phase 2]
A Phase 2 multicenter trial evaluating perioperative tislelizumab combined with nab-paclitaxel for muscle-invasive urothelial bladder cancer…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2022-04-06Clinical Trial Update: An Open Label, Single-arm, Phase 2 Study of Neoadjuvant Nivolumab and Nab-paclitaxel Before Radical Cystectomy for Patients With Muscle-invasive Bladder Cancer (NURE-Combo) [Phase 2]
Phase 2 open-label study evaluating neoadjuvant nivolumab with nab-paclitaxel prior to radical cystectomy in muscle-invasive bladder cancer …
-
CLINICAL_TRIALS trial_result · 2022-03-29Clinical Trial Update: Neoadjuvant Treatment of Upper Urinary and Muscular Invasive Bladder Urothelial Carcinoma [Phase 2]
Phase 2 neoadjuvant trial in upper urinary tract urothelial carcinoma and muscle-invasive bladder cancer; status not provided.
-
CLINICAL_TRIALS trial_result · 2022-03-23Clinical Trial Update: Nivolumab Plus Chemoradiotherapy in Patients With Muscle-invasive Bladder Cancer (MIBC) Not Undergoing Cystectomy [Phase 2]
Phase 2 trial investigating nivolumab with chemoradiotherapy for muscle-invasive bladder cancer in patients not undergoing cystectomy.
-
CLINICAL_TRIALS trial_result · 2022-03-08Clinical Trial Update: A Prospective Study of Neoadjuvant Chemotherapy With Gemcitabine/Platinum in Muscle-Invasive or Locally-Advanced Urothelial Carcinoma of Bladder [Phase 2]
Phase 2 study evaluating neoadjuvant gemcitabine/platinum chemotherapy for muscle-invasive or locally-advanced urothelial carcinoma of the b…
-
CLINICAL_TRIALS trial_result · 2022-02-22Clinical Trial Update: A Study to Evaluate the Safety and Efficacy of Oral APL-1202 in Combination With Tislelizumab Compared to Tislelizumab Alone as Neoadjuvant Therapy in Patients With Muscle Invasive Bladder Cancer [Phase 1, Phase 2]
A clinical trial evaluating the safety and efficacy of oral APL-1202 in combination with tislelizumab vs tislelizumab alone as neoadjuvant t…
-
CLINICAL_TRIALS trial_result · 2022-02-18Clinical Trial Update: Neoadjuvant Dose Dense MVAC in MIBC and Locally Advanced Urothelial Carcinoma [Phase 2]
Phase 2 study update on neoadjuvant dose-dense MVAC therapy for muscle-invasive bladder cancer and locally advanced urothelial carcinoma.
-
CLINICAL_TRIALS trial_result · 2021-12-16Clinical Trial Update: BLASST-1 (Bladder Cancer Signal Seeking Trial): Nivolumab, Gemcitabine, and Cisplatin in Treatment of Muscle Invasive Bladder Cancer (MIBC) Undergoing Cystectomy [Phase 2]
Phase 2 trial update for Nivolumab plus Gemcitabine and Cisplatin in muscle invasive bladder cancer undergoing cystectomy has completed with…
-
CLINICAL_TRIALS trial_result · 2021-09-01Clinical Trial Update: Phase Ib Feasibility Trial of Neoadjuvant Nivolumab/Lirilumab in Cisplatin-Ineligible Muscle-Invasive Bladder Cancer [Phase 1]
Phase Ib feasibility neoadjuvant trial of nivolumab plus lirilumab for cisplatin-ineligible muscle-invasive bladder cancer has completed enr…
-
CLINICAL_TRIALS trial_result · 2021-02-21Clinical Trial Update: Avelumab in Combination With Fluorouracil and Mitomycin or Cisplatin and Radiation Therapy in Treating Participants With Muscle-Invasive Bladder Cancer [Phase 2]
Phase 2 trial evaluating avelumab with fluorouracil and mitomycin or with cisplatin and radiation therapy for muscle-invasive bladder cancer…
-
CLINICAL_TRIALS trial_result · 2020-10-19Clinical Trial Update: Rucaparib in Patients With Locally Advanced or Metastatic Urothelial Carcinoma [Phase 2]
Phase 2 clinical trial of rucaparib in locally advanced or metastatic urothelial carcinoma was terminated; results posted in 2020.
-
CLINICAL_TRIALS trial_result · 2020-08-24Clinical Trial Update: A Window of Opportunity Trial: Avelumab in Non-metastatic Muscle Invasive Bladder Cancer [Phase 1, Phase 2]
Phase 1/2 trial of avelumab in non-metastatic muscle-invasive bladder cancer was terminated; results posted in 2020.
-
CLINICAL_TRIALS trial_result · 2019-11-12Clinical Trial Update: Radical Cystectomy Compared With Chemoradiation for Muscle Invasive Bladder Cancer [NA]
Clinical trial comparing radical cystectomy to chemoradiation for muscle invasive bladder cancer was terminated; results posted in 2019.
-
CLINICAL_TRIALS trial_result · 2019-10-02Clinical Trial Update: Neoadjuvant Dose Dense Gemcitabine and Cisplatin (DD GC) In Patients With Muscle-Invasive Bladder Cancer [Phase 2]
Phase 2 neoadjuvant dose-dense gemcitabine and cisplatin trial in muscle-invasive bladder cancer completed with posted results.
-
CLINICAL_TRIALS trial_result · 2019-09-26Clinical Trial Update: Pegylated Liposomal Doxorubicin, PD-1 in Treating Muscle Invasive Bladder Cancer [Phase 2]
Phase 2 trial exploring pegylated liposomal doxorubicin with a PD-1 inhibitor for muscle invasive bladder cancer is in progress, status curr…
-
CLINICAL_TRIALS trial_result · 2019-08-21Clinical Trial Update: Dose Dense MVAC for Muscle Invasive Bladder Cancer [Phase 2]
Phase 2 trial update for dose-dense MVAC chemotherapy in muscle invasive bladder cancer and high-risk urothelial carcinoma of the upper urin…
-
CLINICAL_TRIALS trial_result · 2019-08-19Clinical Trial Update: Paclitaxel-binding Albumin and Cisplatin as Neoadjuvant Chemotherapy in Patients With Muscle-Invasive Bladder Cancer [Phase 2]
A Phase 2 clinical trial evaluating paclitaxel-binding albumin and cisplatin as neoadjuvant chemotherapy for muscle-invasive bladder cancer.
-
CLINICAL_TRIALS trial_result · 2018-08-28Clinical Trial Update: Chemoradiation for Bladder Preservation After Complete Response to Neoadjuvant Chemotherapy [NA]
A terminated clinical trial investigating chemoradiation for bladder preservation after complete response to neoadjuvant chemotherapy in bla…
-
CLINICAL_TRIALS trial_result · 2018-08-13Clinical Trial Update: Trimodal Therapy Plus Atezolizumab in Muscle-invasive Bladder Cancer [Phase 2]
Phase 2 study investigating trimodal therapy with atezolizumab in muscle-invasive bladder cancer; status is unknown. Focuses on safety issue…
-
CLINICAL_TRIALS withdrawal · 2017-11-17Clinical Trial Update: Gemcitabine Hydrochloride, Cisplatin, and AGS-003-BLD in Treating Patients With Muscle-Invasive Bladder Cancer Undergoing Surgery [NA]
Clinical trial evaluating Gemcitabine hydrochloride, Cisplatin, and AGS-003-BLD for muscle-invasive bladder cancer undergoing surgery has be…
-
CLINICAL_TRIALS research · 2017-06-20Clinical Trial Update: Basal Like Bladder Cancer : Signature and Therapeutic
This entry summarizes a clinical trial investigating basal-like muscle-invasive bladder cancer, focusing on molecular signatures and potenti…